새로운 의료시술의 도입과 임상적용 시의 윤리적 절차 = Ethical Process for Development and Clinical Application of an Innovative Medical Procedure

다국어 초록 (Multilingual Abstract)

Medical care largely depends on developments of medical sciences and technologies. Development of innovative medical procedure have to be based on medical evidence. And ethical climate among individual physicians, academic societies, specialists' organization, and healthcare institution which applies the procedure is as much critical as the ethical stance of the developer. Therefore, it is necessary to make decisions on clinical application and evaluation, social costs and benefits, reimbursement through rational procedure and standards taking into account issues like medical evidence and conflict of interests. Especially, in the case of innovative surgical and surgico-medical procedure, the adoption has almost been up to non-formal studies until recently. Formal review process based on basic principles of biomedical research ethics and evidence-based medicine, is to be proposed for development of innovative surgical and medical procedures. And this process is to be an integral part of biomedical technology assessment and ethical regulation.
This paper suggests an ethical guideline for ethical review and evaluation of a new medical procedure from its initial attempt to clinical application. Though focused on innovations, this suggested guideline is also applicable to a new medical procedure. The paper consists of four parts. Firstly, it outlines the general discussion about surgical innovations from the ethical viewpoint. Secondly, prior researches about the need of guideline are reviewed. Thirdly, under this background, basic principles for process of review and evaluation, and fourthly, the very process is proposed. Lastly, the further suggestions in connection with health care policy are given.

참고문헌 (Reference)

1 박재현, "평생의학교육의 의사-제약회사 관계" 한국의료윤리학회 14 (14): 335-342, 2011

2 배종면, "임상진료지침 개발 및 확산에 있어 이해상충문제" 한국의료윤리학회 14 (14): 225-232, 2011

3 홍진표, "의사-제약회사 상호작용이 처방에 미치는 영향" 한국의료윤리학회 14 (14): 203-213, 2011

4 김승후, "의사-제약회사 상호관계가 연구에 미치는 영향" 한국의료윤리학회 14 (14): 343-360, 2011

5 강명신, "의사-제약산업체 상호작용에서의 이해상충 관리" 한국의료윤리학회 14 (14): 361-371, 2011

6 이일학, "의료인-제약산업 관계의 이해상충과 윤리적 원칙" 한국의료윤리학회 14 (14): 193-201, 2011

7 신은희, "의료법 쌍벌죄 규정에 대한 의료법리학적 문제제기" 한국의료윤리학회 14 (14): 372-379, 2011

8 정유석, "의대생/전공의와 제약회사의 윤리적 관계" 한국의료윤리학회 14 (14): 215-223, 2011

9 "신의료기술평가에관한규칙 제2조[일부개정 2008.3.3 보건복지부령 제1호]"

10 노먼 대니얼스, "분배정의와 의료보장" 나눔의집 2009

11 이상무, "근거중심 보건의료: 끊어진 선순환의 고리를 찾아서" 대한의사협회 52 (52): 532-535, 2009

12 "www.cimit.org"

13 Margo CE, "When is surgery research? Towards an operational definition of human research" 27 (27): 40-43, 2001

14 Robert, "This figure is quoted in their article from Liaropoulus L"

15 Moore FD, "Therapeutic innovation: ethical boundaries in the initial clinical trials of new drugs and surgical procedures" 20 (20): 212-227, 1970

16 McCullough LB, "Standard of care, innovation, and research in surgery: a problem in research ethics or in professional medical ethics?, In Ethical Guidelines for Innovative Surgery" University Publishing Group 53-, 2006

17 McCullough LB, "Standard of care, innovation and research in surgery: a problem in research ethics of professional ethics? Ethical Guidelines for Innovative Surgery, Reitsma and Moreno. 2006. Human Subjects Protection Program Guidance Document ver.1.0 Sept. 15, 2009"

18 Biffl WL, "Responsible development and application of surgical innovations: a position statement of the university surgeons" 206 (206): 1204-1209, 2008

19 Biff WL, "Responsible development and application of surgical innovations: a position statement of the university surgeons" 206 (206): 1204-1209, 2008

20 Sharpe VA, "Promoting patient safety: an ethical basis for policy deliberation" 33 (33): S1-S20, 2003

21 Spodik D, "Numerators without denominators: there is no FDA for the surgeon" 232 (232): 1-32, 1975

22 Brown IT, "Medical technology horizon scanning" 28 (28): 200-203, 2005

23 Wall J, "From Idea to Bedside: The Process of Surgical Invention and Innovation. Key Topics in Surgical Research and Methodology" 647-655, 2010

24 Ashrafian H, "Evidence-Based Surgery, In Key Topics in Surgical Research and Methodology" Springer 9-26, 2010

25 Gillett G, "Ethics of surgical innovation" 88 (88): 897-898, 2001

26 Shinebourne EA, "Ethics of innovative cardiac surgery" 52 (52): 597-601, 1984

27 Reitsma AM, "Ethical regulations for innovative surgery: the last frontier?" 194 (194): 792-801, 2002

28 Reitsma AM, "Ethical regulations for innovative surgery: the last frontier?" 194 : 792-801, 2002

29 McKneally MF, "Ethical problems in surgery: innovation leading to unforseen complications" 23 (23): 786-788, 1999

30 Reitsma AM, "Ethical Guidelines for Innovative Surgery" University Publishing Group 2006

31 London AJ, "Cutting surgical practices at the joints: individuating and assessing surgical procedures, In The emperor's new scar: the ethics of placebo surgery" University of Wollongong 2006

32 Spilker B, "Creating an IRB checklist to protect human subjects in clinical trials" 34-36, 2002

33 Eddy TM, "Clinical Decision Making: From Theory to Practice" Jones and Bartlett Publishers 245-, 1996

34 Wilson CB, "Adoption of new surgical technology" 332 (332): 332-7533, 2006

35 Robert G, "'Early warning systems for identifying new healthcare technologies" 3 (3): 1-118, 1999